Journal of Pediatric Neurology 2020; 18(02): 114-117
DOI: 10.1055/s-0039-1683870
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Brain Tuberculomas as BCGitis Complication Presenting with Epileptic Spasms: A Case Report

Basma Ayadi
1   Child Neurology Department, Hedi Chaker University Hospital, Sfax, Tunisia
,
Fatma Kamoun Feki
1   Child Neurology Department, Hedi Chaker University Hospital, Sfax, Tunisia
2   Child Neurology Department Search Unit “Neuropédiatrie” UR12ES16, Sfax University, Tunisia
,
Siham Ben Nsir
1   Child Neurology Department, Hedi Chaker University Hospital, Sfax, Tunisia
2   Child Neurology Department Search Unit “Neuropédiatrie” UR12ES16, Sfax University, Tunisia
,
Wafa Bouchaala
1   Child Neurology Department, Hedi Chaker University Hospital, Sfax, Tunisia
2   Child Neurology Department Search Unit “Neuropédiatrie” UR12ES16, Sfax University, Tunisia
,
Zeineb Mnif
3   Radiology Department, Hedi Chaker University Hospital, Sfax, Tunisia
,
Mounir Ben Jemaa
4   Department of Infectious Diseases, Hedi Chaker University Hospital, Sfax, Tunisia
,
Chahnez Triki
1   Child Neurology Department, Hedi Chaker University Hospital, Sfax, Tunisia
2   Child Neurology Department Search Unit “Neuropédiatrie” UR12ES16, Sfax University, Tunisia
› Author Affiliations
Further Information

Publication History

02 December 2018

11 February 2019

Publication Date:
13 March 2019 (online)

Abstract

Central nervous system (CNS) BCGitis is a rare but a very severe complication of the Bacille Calmette–Guerin (BCG) vaccine. It could be a diagnostic challenge that may lead to a delay in treatment. A 5-month-old boy presented with infantile spasms, had posted natal BCG vaccination and developed brain tuberculomas as brain BCGitis. Laboratory findings were normal. He received 14 months of antitubercular regimen with good tolerance and both clinical and radiological improvement. The main difficulty in brain BCGitis is to make a diagnosis that requires histological or bacteriological examination. A good evolution without sequel could be seen if it is treated early.

 
  • References

  • 1 Ben Amar J, Hassairi M, Ben Salah N. , et al. Pulmonary tuberculosis: diagnostic delay in Tunisia. Med Mal Infect 2016; 46 (02) 79-86
  • 2 Mjid M, Cherif J, Ben Salah N. , et al. Épidémiologie de la tuberculose. Rev Pneumol Clin 2015; 71 (2-3): 67-72
  • 3 Daei Parizi M, Kardoust Parizi A, Izadipour S. ; DaeiParizi M. Evaluating clinical course of BCG lymphadenitis and factors affect on it during a 5-year period in Kerman, Iran. J Trop Pediatr 2014; 60 (02) 148-153
  • 4 Hwang SM, Ahn SK, Lee SH, Choi EH. Lichen striatus following BCG vaccination. Clin Exp Dermatol 1996; 21 (05) 393-394
  • 5 Hesseling AC, Rabie H, Marais BJ. , et al. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 2006; 42 (04) 548-558
  • 6 Riordan A, Cole T, Broomfield C. Fifteen-minute consultation: Bacillus Calmette-Guérin abscess and lymphadenitis. Arch Dis Child Educ Pract Ed 2014; 99 (03) 87-89
  • 7 Talbot EA, Perkins MD, Silva SFM, Frothingham R. Disseminated bacille Calmette-Guérin disease after vaccination: case report and review. Clin Infect Dis 1997; 24 (06) 1139-1146
  • 8 Bolursaz MR, Lotfian F, Velayati AA. Bacillus Calmette-Guérin vaccine complications in Iranian children at a University Hospital. Allergol Immunopathol (Madr) 2017; 45 (04) 356-361
  • 9 Bukhari E, Alzahrani M, Alsubaie S, Alrabiaah A, Alzamil F. Bacillus Calmette-Guerin lymphadenitis: a 6-year experience in two Saudi hospitals. Indian J Pathol Microbiol 2012; 55 (02) 202-205
  • 10 Kourime M, Akpalu EN. , H Ouair, et al. Bécégites de l'enfant: diagnostic, classification et exploration [Article in French]. Arch Pediatr 2016; 23 (07) 754-759
  • 11 Goraya JS, Virdi VS. Treatment of Calmette-Guérin bacillus adenitis: a metaanalysis. Pediatr Infect Dis J 2001; 20 (06) 632-634
  • 12 Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet 1995; 346 (8,974): 581
  • 13 Remiszewski P, Roszkowska-Sliz B, Winek J. , et al. Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNgammaR1 deficiency. Respiration 2006; 73 (03) 375-378
  • 14 Casanova JL. Infection disséminée idiopathique par le BCG ou les mycobactéries atypiques. Arch Pediatr 1997; 4 (09) 883-885
  • 15 Garg RK. Tuberculosis of the central nervous system. Postgrad Med J 1999; 75 (881) 133-140
  • 16 Golub V, Malhotra P, Patel S. Mycobacterial brain tuberculomas due to Bacille Calmette-Guérin intravesical chemotherapy for bladder cancer: A case report and literature review. Can J Infect Dis Med Microbiol 2011; 22 (03) 104-106
  • 17 Ehrengut W. BCG-induced inflammation during childhood and in pregnancy. Additionally a contribution to BCG-induced necrotising cerebral arteritis [Article in German]. Klin Padiatr 1990; 202 (05) 303-307
  • 18 Parent ME, Richer M, Liang P. The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis. Clin Rheumatol 2018 doi: 10.1007/s10067-018-4136-9
  • 19 Venkataraman A, Yusuff M, Liebeschuetz S, Riddell A, Prendergast AJ. Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions. Vaccine 2015; 33 (41) 5470-5474
  • 20 Ben Achour N, Nâas A, Hammami N. , et al. Une lésion mésencéphalique avec rehaussement annulaire. Arch Pediatr 2017; 24 (01) 52-54
  • 21 Kanellakopoulou K, Pagoulatou A, Stroumpoulis K. , et al. Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of humans: implication for a bactericidal effect. J Antimicrob Chemother 2008; 61 (06) 1328-1331
  • 22 Alffenaar JWC, van Altena R, Bökkerink HJ. , et al. Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis. Clin Infect Dis 2009; 49 (07) 1080-1082